NFKB1 and Huntington disease: • Enhanced activation of NFκB-p65 activity in the astrocytes of HD patients and mouse models • Blockage of IKK ameliorates astrocyte-mediated NFκB-dependent inflammatory response and neuro-toxicity in HD R6/2 mouse model